Almirall announces positive phase III results for drug against psoriasis

Thursday, Sep 29, 2016

Almirall SA Announces positive results from the phase III trial showing efficacy of dimethyl fumarate, a new systemic oral drug for patients with chronic plaque psoriasis.

To present the results on Sep. 29 at the dermatology congress in Vienna.


Source :